NCT06321692View on ClinicalTrials.gov

Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Neuroendocrine Tumors

Interventions

OTHER

Evaluation of blood levels of biomarkers of cardiac damage

Evaluation of ultra-sensitive troponin I, BNP, NT-proBNP, and ST2 in patients with diagnosed neuroendocrine tumours (NET) with or without carcinoid syndrome

Trial Locations (1)

Unknown

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER